Shuttle Pharmaceuticals Holdings, Inc. (SHPH): Cash & Equivalents
$334.0K
As of 2025-12-31
$90.2K
As of 2026-06-30
-65.9%
3-year compound annual growth
| Period ended | Cash & Equivalents | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $334.0K | -82.6% | 2026-03-31, Balance as of period end |
| 2024-12-31 | $1.92M | -25.5% | 2026-03-31, Balance as of period end |
| 2023-12-31 | $2.58M | -69.4% | 2025-02-26, Balance as of period end |
| 2022-12-31 | $8.42M | n/m | 2024-09-04, Balance as of period end |
| 2021-12-31 | $504.7K | n/a | 2023-03-15, Balance as of period end |
Cash & Equivalents at similar companies
| Company | Year ended | Cash & Equivalents | Change YoY |
|---|---|---|---|
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | 2025-12-31 | $334.0K | -82.6% |
| Longeveron Inc. (LGVN) | 2025-12-31 | $4.66M | -75.8% |
| Genprex, Inc. (GNPX) | 2025-12-31 | $7.83M | +388.9% |
| Oragenics Inc (OGEN) | 2025-12-31 | $4.40M | +408.7% |
| Medicus Pharma Ltd. (MDCX) | 2025-12-31 | $8.71M | +109.0% |
| Korsana Biosciences, Inc. (KRSA) | 2025-12-31 | $3.24M | +0.2% |
| Lantern Pharma Inc. (LTRN) | 2025-12-31 | $4.42M | -41.1% |
| Lunai Bioworks Inc. (LNAI) | 2026-06-30 | $1.71M | n/m |
| Decoy Therapeutics Inc. (DCOY) | 2025-12-31 | $10.71M | +339.9% |
Compare SHPH, LGVN, GNPX, OGEN side by side · Screen every company in Pharmaceutical Preparations ↗